NCT07652645

Brief Summary

Around 10% of post-active veterans experience post-traumatic stress disorder (PTSD) many years post-mission. PTSD in veterans is frequently associated with challenges in emotion regulation, aggression, suicidality, and financial and psychosocial stress. In 2018, a 12-week clinical treatment programme, the Veterans Intensive Treatment Unit (VIBU), was developed for veterans experiencing these psychiatric symptoms, for whom conventional treatments had proven ineffective. The VIBU provides patients with trauma-focused and dialectical behaviour therapy (DBT). A recent study revealed that the VIBU was effective in reducing psychiatric symptoms. However, a recurrence of symptoms was observed in patients a few months after discharge. Consequently, an aftercare programme consisting of hybrid DBT is offered to consolidate and repeat the DBT skills and apply them in daily life.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
27mo left

Started Jun 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jun 2026Oct 2028

First Submitted

Initial submission to the registry

February 23, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 17, 2026

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2028

Last Updated

June 17, 2026

Status Verified

June 1, 2026

Enrollment Period

2.3 years

First QC Date

February 23, 2026

Last Update Submit

June 11, 2026

Conditions

Keywords

Emotional dysregulationPTSDDBTHybrid DBTVeterans

Outcome Measures

Primary Outcomes (2)

  • PTSD Checklist for the DSM-5 (PCL-5)

    One of the two main outcomes of this study is PTSD symptom score. The self-report questionnaire contains 20 questions with answer options ranging from '0 = Not at all' to '4 = Extremely', resulting in a score between 0-80. A higher score indicates more likelyhood of having PTSD.

    From the baseline to the end of the follow-up period (between 12-17 months)

  • Difficulties in Emotion Regulation Scale Short Form (DERS-SF)

    One of the two main outcomes of this study is emotion dysregulation severity. The self-report questionnaire contains 18 questions with answer options from '1 = Almost never' to '5 = Almost always', resulting in a score between 18-90. A higher score indicates more difficulties with regulation emotions.

    From the baseline to the end of the follow-up period (between 12-17 months)

Secondary Outcomes (1)

  • REFRESH - monitoring

    From enrollment to (favourably) the end of the follow-up period (between 12-17 months)

Other Outcomes (12)

  • Outcome Questionnaire (OQ-30.2)

    From the baseline to the end of the follow-up period (between 12-17 months)

  • Alcohol Use Disorders Identification Test (AUDIT)

    From the baseline to the end of the follow-up period (between 12-17 months)

  • Drug Use Disorders Identification Test (DUDIT)

    From the baseline to the end of the follow-up period (between 12-17 months)

  • +9 more other outcomes

Study Arms (1)

Hybrid DBT

EXPERIMENTAL

All participants will follow the same hybrid DBT program (i.e., group sessions, individual sessions and online homework assignments). Randomization will determine the length of the waiting period between baseline and start of the intervention (i.e., hybrid DBT).

Behavioral: Hybrid dialectical behavior therapy

Interventions

Hybrid DBT will be provided to veterans who have followed a 3-month inpatient DBT treatment. The hybrid DBT will include face-to-face skill groups, online individual sessions and online homework assignements.

Also known as: DBT, Dialectical behavior therapy
Hybrid DBT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult veteran (18 years or older), treated at Sinai Center, with knowledge of DBT
  • Primairy diagnosis of PTSD, determined with CAPS-5, resulting from war-related traumas
  • Stable for four weeks on their medication (type and doses)
  • Able to to do online homework assignments and communicate with their therapist via an eHealth platform
  • Dutch speaking

You may not qualify if:

  • Chronic psychosis (psychotic features as comorbidity from PTSD is allowed) or bipolar disorder type 1
  • IQ below 80 or cognitive disorders
  • Severe self-harming behaviour, such as auto-mutilation or suicidal ideations as main problem
  • Following day treatments or other intensive treatment for residual symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sinai Center

Amstelveen, North Holland, 1186 AM, Netherlands

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticSubstance-Related Disorders

Interventions

Dialectical Behavior Therapy

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersChemically-Induced Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Multiple baseline design
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2026

First Posted

June 17, 2026

Study Start

June 1, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

October 1, 2028

Last Updated

June 17, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Very sensitive personal information.

Locations